Phase I/II ImmunityBio hAd5-S-Fusion+N-ETSD Vector (non-replicating) 540 18–
80 1 (boost) Partial Open-label (phase I), double-blind (phase
II) USA 01/05/2021 30/09/2021 NCT04845191 Not yet recruiting

fwfwefffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffwfwefewfewfewfwefewfewwfergjuhnwotighogi3u5g903tgh093gh5940g549-g8359-g8h3459g-84h9g8h53g4-f23f23f23f23f34u34gh-934hg-938gh-594gh2594-gh4-59gh4-59gh24-59g8h59g-h8459g-8h59g-h49g-h459g-h45g